Rituxan / MabThera 100 mg Alternative – Relyto (Rituximab) 100 mg IV infusion | Incepta Pharmaceuticals
Relyto 100 mg (Rituximab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Rituxan / MabThera (Roche / Genentech).
Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Rituxan / MabThera 500 mg Alternative – Relyto (Rituximab) 500 mg IV infusion | Incepta Pharmaceuticals
Relyto 500 mg (Rituximab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Rituxan / MabThera (Roche / Genentech).
Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Sprycel 100 mg Alternative – Dasanix (Dasatinib) 100 mg Tablet | Beacon Pharmaceuticals
Sprycel 20 mg Alternative – Dasanix (Dasatinib) 20 mg Tablet | Beacon Pharmaceuticals
Stivarga 40 mg Alternative – Regocent (Regorafenib) 40 mg Tablet | Incepta Pharmaceuticals
Regocent 40 mg (Regorafenib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Stivarga (Bayer).
Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Stivarga 40 mg Alternative – Regora (Regorafenib) 40 mg Tablet | Beacon Pharmaceuticals
Sutent 50 mg Alternative – Sunicent (Sunitinib) 50 mg Capsule | Incepta Pharmaceuticals
Sunicent 50 mg (Sunitinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Sutent (Pfizer).
Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Sutent 50 mg Alternative – Sunitix (Sunitinib) 50 mg Capsule | Beacon Pharmaceuticals
Tabrecta 200 mg Alternative – Capmaxen (Capmatinib) 200 mg Tablet | Everest Pharmaceuticals
Capmaxen 200 mg (Capmatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Tabrecta (Novartis). It belongs to the MET inhibitor class and is used in selected MET exon 14 skipping non-small cell lung cancer.
Active ingredient: Capmatinib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Tagrisso 80 mg Alternative – Osicent (Osimertinib) 80 mg Tablet | Incepta Pharmaceuticals
Osicent 80 mg (Osimertinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tagrisso (AstraZeneca).
Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Tagrisso 80 mg Alternative – Osimert (Osimertinib) 80 mg Tablet | Everest Pharmaceuticals
Osimert 80 mg (Osimertinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Tagrisso (AstraZeneca). It belongs to the EGFR tyrosine kinase inhibitor class and is used in selected EGFR-mutated non-small cell lung cancer.
Active ingredient: Osimertinib
Strength: 80 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.